The pill form of Novo Nordisk’s drug Ozempic can cut the risk of heart attacks and strokes, according to a new study

Rybelsus, the oral form of semaglutide, was found to reduce the risk of major adverse heart events in adults with Type 2 diabetes by 14%

Related Videos

• 

  Venu CEO JW Roth - Legends Global brings ‘prove excellence’ to new partnership

• 

  NYSE and State Street to celebrate Fearless Girl statue with summer block party

• 

  Oliver Scholars CEO Danielle Moss Cox discusses elevating students’ aspirations

• 

  Vertical Aerospace exec explains why it was important to join Project VERTI-GO

• 

  Market expert Michael Landsberg predicts Fed's rate hike path for rest of 2026

• 

  ICE Brent crude oil surpasses $100 a barrel for first time since May

• 

  Future Today Strategy Group CEO Amy Webb talks AI revolution at Aspen Ideas